Jane Street
NYMX

Jane Street’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Jane Street’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-13,600
Closed -$44K – 4767
2016
Q3 		$44K Buy
+13,600
New +$44.5K ﹤0.01% 3897

Other funds holding NYMX

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
CF
Corrigan Financial Middletown, Rhode Island $485M AUM 4.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return
SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street's NYMX Position: Q1 2023 in Review

Jane Street sold out of Nymox Pharmaceutical Corp (NYMX) in Q1 2023, closing a stake of 25,126 shares — an estimated $8.12K sold.

Jane Street first reported a position in NYMX in Q1 2020 and held it in 6 quarters. The position peaked at $296K in Q2 2020. 35 funds tracked by Wall St. Rank hold NYMX as of Q1 2023.

  • Jane Street reported no remaining Nymox Pharmaceutical Corp position as of Q1 2023 after selling out during the quarter.
  • Jane Street sold 25,126 Nymox Pharmaceutical Corp shares in Q1 2023, an estimated $8.12K.
  • Jane Street first reported a position in Nymox Pharmaceutical Corp in Q1 2020 and held it in 6 quarters.
  • Jane Street's Nymox Pharmaceutical Corp position peaked at $296K in Q2 2020.
  • 35 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.